U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Enhanced Drug Distribution Security in 2023 Under the DSCSA - 10/05/2021
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Enhanced Drug Distribution Security in 2023 Under the DSCSA
October 5, 2021

Scheduled
Date:
October 5, 2021

Visit CDER Small Business and Industry Assistance Page

 

 

Download Slides

ABOUT THIS WEBINAR
Please join us as FDA will:

  • Discuss enhanced drug distribution security requirements that go into effect in 2023 under the Drug Supply Chain Security Act (DSCSA).
  • Explain how enhanced drug distribution security will help protect patients from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful.
  • Summarize updates on implementation of supply chain security requirements under the DSCSA.

 

TOPICS COVERED

  • Pharmaceutical supply chain and distribution
  • Drug traceability and verification
  • Supply security requirements under the DSCSA
  • Enhanced drug distribution security under DSCSA

 

INTENDED AUDIENCE

  • Trading partners (Manufacturers, Repackagers, Wholesale Distributors, Dispensers (primarily Pharmacies), and Third-party Logistics Providers (3PLs))
  • Regulatory affairs professionals working on compliance with DSCSA requirements
  • Solution providers or consultants working on DSCSA requirements
  • Other Federal or State regulators

 

FDA SPEAKERS

Connie Jung, RPh, PhD
Senior Advisor for Policy
Office of Drug Security, Integrity and Response (ODSIR) | Office of Compliance (OC) | CDER | FDA

Abha Kundi, JD, MPH
Regulatory Counsel
Division of Supply Chain Integrity | ODSIR | OC | CDER | FDA

 

FDA RESOURCES

Back to Top